(Q34214842)

English

Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease (English)

1 reference

Europe PubMed Central

31 July 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eliezer Masliah

2

object named as

Eliezer Masliah

1 reference

Europe PubMed Central

31 July 2017

author name string

Cristine Alves da Costa

1

1 reference

Europe PubMed Central

31 July 2017

Frédéric Checler

3

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

16 July 2003

1 reference

Europe PubMed Central

31 July 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

31 July 2017

278

1 reference

Europe PubMed Central

31 July 2017

39

1 reference

Europe PubMed Central

31 July 2017

37330-37335

1 reference

Europe PubMed Central

31 July 2017

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Alpha-synuclein in Lewy body disease and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Polyglutamine expansions: proteolysis, chaperones, and the dangers of promiscuity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Mechanisms of neurodegenerative disorders: Part 1: protein aggregates.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Clonal cell lines produced by infection of neocortical neuroblasts using multiple oncogenes transduced by retroviruses

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Definition of a consensus binding site for p53

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Recent advances on alpha-synuclein cell biology: functions and dysfunctions.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Properties of NACP/alpha-synuclein and its role in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Alpha-synuclein and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

A potential role for apoptosis in neurodegeneration and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306083200

21 January 2018

Identifiers

10.1074/JBC.M306083200

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34214842&oldid=1543331149"